Mohammad Usman Shaikh

This inventor holds 7 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Wockhardt Limited, Other. Active years: 2012-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mohammad Usman Shaikh. Retrieved from https://idiyas.com/inventor/mohammad-usman-shaikh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 (Patent Applications = 4)

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 10.3

ph-index = 2

Forward Citations = 19(Granted Patents)

Location History:

Ahmednagar, IN (2012 - 2016)
Shrirampur, IN (2015 - 2019)

Company Filing History:

6 out of 117

Wockhardt Limited

patents

1 out of 834,570

Other

patents

Years Active: 2012-2019

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10519155 - 1,6-diazabicyclo [3,2,1] octan-7-one derivatives and their bacterial infections (2019-12-31),

2. 9732081 - 1,6-diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections (2017-08-15),

3. 9688677 - Process for preparation of sodium (2S, 5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxylate (2017-06-27),

4. 9499544 - Nitrogen containing heterocyclic compounds (2016-11-22),

5. 9127004 - Nitrogen containing heterocyclic compounds (2015-09-08),

6. 9006230 - 1,6-diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections (2015-04-14),

7. 8288416 - Substituted piperidinophenyl oxazolidinones (2012-10-16),

Title: **Innovator Spotlight: Mohammad Usman Shaikh**

Introduction

Mohammad Usman Shaikh, based in Shrirampur, India, is a noteworthy inventor with a robust portfolio of seven patents. His contributions span the pharmaceutical field, particularly focusing on compounds that address bacterial infections.

Latest Patents

Among his most recent innovations are the patents related to 1,6-diazabicyclo [3,2,1] octan-7-one derivatives. These patents disclose compounds of Formula (I) that have significant applications in preventing or treating bacterial infections. His research has opened new avenues for the treatment of bacterial pathogens, emphasizing the importance of innovative solutions in modern medicine.

Career Highlights

Mohammad Usman Shaikh has honed his expertise while working at reputed organizations, including Wockhardt Limited. His career is marked by continuous exploration of chemical formulations that contribute to advances in healthcare and medicine.

Collaborations

Throughout his journey, Mohammad has collaborated with notable professionals such as Vijaykumar Jagdishwar Patil and Ravikumar Tadiparthi. These partnerships have enriched his research and allowed for the exchange of ideas that further propel innovation in the pharmaceutical sector.

Conclusion

Mohammad Usman Shaikh exemplifies the spirit of innovation in the realm of pharmaceuticals, addressing significant health challenges through his discoveries. With a track record of valuable patents, he continues to be a pivotal figure in the fight against bacterial infections, driving progress in medical science.

Profile summary based on public USPTO records.